Alexion Pharmaceuticals Profile

135.2
USD 3.74  2.69%
135.2Last Month High 143.84 
134.81Trading Day  High 139.39 

Sale by Vikas Sinha of 5500 shares of Alexion Pharmaceuticals

Alexion Pharmaceuticals Inc insider trading alert for sale of common stock par value $.0001 per share by Vikas Sinha, SVP CFO, on October 21, 2017. This event was filed by Alexion Pharmaceuticals I with SEC on 2011-07-27. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Alexion Pharmaceuticals Summary

Alexion Pharmaceuticals Inc (ALXN) is traded on NASDAQ in USA. It is located in CONNECTICUT, U.S.A and employs 2,924 people. Alexion Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with current market capitalization of 31.35 B. Alexion Pharmaceuticals Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 223.18 M outstanding shares of which 5.07 M shares are presently shorted by private and institutional investors with about 2.63 trading days to cover. ALEXION PHARM INC currently holds about 1.45 B in cash with 1.26 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.48.
Check Alexion Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Alexion Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Alexion Pharmaceuticals Against Markets

Current Ratings  

Alexion Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 14% 
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes lifetransforming therapeutic products. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAlexion Pharmaceuticals Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationCONNECTICUT, U.S.A
Business Address100 College Street, New Haven, CT 06510, United States
Foreign Associate  Switzerland
ExchangeNASDAQ
CIK Number00899866.0
ISINUS0153511094
CUSIP015351109
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.alxn.com
Contact Number475 230 2596
CurrencyUSD - US Dollar

Recommendations

Alexion Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
160.5Buy16Odds
Alexion Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Alexion Pharmaceuticals Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Alexion Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.09April 27, 2017
Alexion Pharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate